Cover Image

Factors associated with sex differences in viral non‐suppression in the Swedish InfCareHIV cohort: An observational real‐world study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Maria Lindh, Johanna Brännström, Anton Reepalu, Veronica Svedhem, Åsa Mellgren
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	HIV Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Late diagnosis of HIV persists in Sweden: Differing social determinants among migrant and non‐migrant people with HIV
by: Sara Falk, et al.
Published: (2026)

Factors mediating and associated with immunological response in women living with HIV in Sweden: A nationwide register‐based study
by: Josefin Nilsson, et al.
Published: (2025)

Factors associated to the control of viral load in HIV positive patients
by: Leticia Ferraz Pamplona
Published: (2021)

HIV drug resistance, viral suppression, and survival in children living with HIV in Brazil
by: Alexandre A. C. Mendes‐Ferreira, et al.
Published: (2024)

Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV
by: Kyle Ring, et al.
Published: (2025)

The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infections
by: Daniel Simões, et al.
Published: (2024)

Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV
by: Maria Saumoy, et al.
Published: (2025)

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort
by: Inés Suárez‐García, et al.
Published: (2025)

Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY cohort
by: Jesús Troya, et al.
Published: (2026)

Real‐world clinical and laboratory changes after switching to two‐drug regimen in HIV ‐suppressed individuals: 48 weeks and beyond
by: Tommy Hing‐cheung Tang, et al.
Published: (2026)

Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis
by: Gundolf Schuettfort, et al.
Published: (2025)

Predictors for choosing doravirine‐based versus INSTI‐based regimen in ART‐naïve and ART‐experienced people with HIV in real‐world setting: Data from the Icona cohort
by: Antonella d'Arminio Monforte, et al.
Published: (2024)

Effectiveness and safety of two‐drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV : Data from the COMBINE ‐2 study
by: Cristina Mussini, et al.
Published: (2026)

Real‐world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV‐1 aged over 50 years who are virologically suppressed
by: C. Piñeiro, et al.
Published: (2024)

An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe
by: Annemarie Rinder Stengaard, et al.
Published: (2026)

Clinical HIV outcome trajectories associated with a history of child protective service out‐of‐home care: Longitudinal cohort findings with women living with HIV in Canada
by: Carmen H. Logie, et al.
Published: (2024)

Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish RELATIVITY cohort
by: Jesús Troya, et al.
Published: (2025)

HIV ‐1 viral load and reservoir size remain stable following SARS ‐ CoV ‐2 mRNA vaccination in people with HIV
by: Oscar Kieri, et al.
Published: (2026)

Worldwide molecular epidemiology of HIV
by: Henry I Z Requejo
Published: (2006)

Psychosocial factors associated with HIV testing in Colombian university students
by: Juan P. Sanabria-Mazo
Published: (2020)

Metabolic dysfunction‐associated liver disease predicts incident liver fibrosis in people with HIV mono‐infection: A cohort study
by: Juliana Fittipaldi, et al.
Published: (2025)

THE FACES OF VULNERABILITY - WOMEN, MOTHER, HIV POSITIVE: REFLECTIONS ON WOMEN HEALTH NURSING
by: Isabel Catarina Correia Braga
Published: (2010)

Perianal lesions in men who have sex with men living with HIV : Risk of precancer and cancer
by: Shima Rastegar, et al.
Published: (2026)

Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach
by: Paula Natalia Hernández‐Trujillo, et al.
Published: (2025)

FATORES DE RISCO PARA A MATERNIDADE ENTRE ADOLESCENTES VIVENDO COM HIV
by: Gabriela Vescovi
Published: (2016)

Sex differences in cardiovascular disease and associated factors in people living with HIV : Evidence from All of Us program
by: Hao Zhang, et al.
Published: (2025)

Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study
by: Mailin Waldecker, et al.
Published: (2025)

“La Familia” HIV prevention program: A focus on disclosure and family acceptance for Latino immigrant MSM to the USA
by: Rita M Melendez
Published: (2013)

SARS‐CoV‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort
by: O. Fursa, et al.
Published: (2024)

Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir
by: Pierluigi Francesco Salvo, et al.
Published: (2025)

Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4‐FHDH)
by: S. Abgrall, et al.
Published: (2024)

Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV
by: Montserrat Laguno, et al.
Published: (2024)

Cardiovascular disease in people living with HIV in Malaysia: A competing risks cohort analysis
by: Hoon Shien Teh, et al.
Published: (2025)

Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain
by: Inés Suárez‐García, et al.
Published: (2025)

Anal cancer screening in men who have sex with men living with HIV : The pilot of anal screening study ( PASS )
by: Clare E. F. Dyer, et al.
Published: (2025)

Morbidity and risk factors of COVID ‐19 in people with HIV ‐1 in Europe: A combined observational cohort and nested case–control study
by: Georg M. N. Behrens, et al.
Published: (2025)

Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia
by: Kidanu Hurisa Chachu, et al.
Published: (2025)

Sexual dysfunction care needs of gay, bisexual, and other men who have sex with men living with HIV in Montreal, Canada
by: Francesco Avallone, et al.
Published: (2025)

HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)
by: Minyang Xiao, et al.
Published: (2025)

Do people with HIV really have the choice between oral and injectable ART ? Evidence from a multicentric survey in the Swiss HIV cohort study
by: Yonas Martin, et al.
Published: (2026)